SEC Form 4 · accession 0001140361-16-051675
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Feb 9, 2016
Accepted (ET)
Feb 11, 2016 · 12:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Feb 9, 2016 | P | 13,026 | $0.7896 | A | 6,469,670 | I | By Trust |
| Common StockF3,F1 | Feb 10, 2016 | P | 54,187 | $0.7742 | A | 6,523,857 | I | By Trust |
| Common Stock | holding | — | — | — | 14,800 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.
- F2This price reflects the weighted average purchase price for open-market purchases of shares of Common Stock ("Shares") made by the Reporting Persons on February 9, 2016, within a $1.00 range. The actual prices for these transactions range from $.7601 to $.80, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- F3This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on February 10, 2016, within a $1.00 range. The actual prices for these transactions range from $0.765 to $0.78, inclusive.